Mumbai, India

Kalpana Sanjay Joshi

This inventor holds 38 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Cipla Limited, Piramal Enterprises Limited, Cipla (UK) Limited. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kalpana Sanjay Joshi. Retrieved from https://idiyas.com/inventor/kalpana-sanjay-joshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 

% Patents Active = 81.6

 

 

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 93(Granted Patents)


Location History:

  • Mumbai, IN (2012 - 2014)
  • Maharashtra, IN (2003 - 2022)
  • Thane, IN (2007 - 2023)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Cancer Treatment
Hypertension
Combination Therapy
Hepatitis C
PAR-4 Agonists
Neurodegenerative Diseases
Thienopyridine Derivatives
Inhibitors of Cyclin Dependent Kinases
Synergistic Pharmaceutical Combinations
Herbal Composition
Flavones
38 patents (USPTO):Explore Patents

Title: Kalpana Sanjay Joshi: Innovator in Pharmaceutical Compositions

Introduction

Kalpana Sanjay Joshi is a renowned inventor based in Mumbai, India, recognized for her significant contributions to the pharmaceutical industry. With a remarkable portfolio of 38 patents, she has made substantial strides in the development of pharmaceutical compositions that address critical health challenges.

Latest Patents

Among her latest inventions, one patent details a pharmaceutical composition comprising ((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)oxy)methyl pivalate or a pharmaceutically acceptable derivative thereof, which can be used in medical applications. Another notable patent presents an oral or injectable pharmaceutical composition aimed at treating diseases caused by retroviruses or hepatitis B viruses. This composition includes a therapeutically effective amount of at least one anti-retroviral drug along with a pharmacokinetic booster or enhancer, complete with methods and kits for use.

Career Highlights

Kalpana has built her career by associating with leading companies in the pharmaceutical sector, including Cipla Limited and Piramal Enterprises Limited. Her work in these esteemed organizations has furthered her expertise and innovation in drug development, showcasing her ability to translate scientific research into viable therapeutic solutions.

Collaborations

Throughout her illustrious career, Kalpana Sanjay Joshi has collaborated with esteemed colleagues including Geena Malhotra and Jeevan Ghosalkar. These collaborations have allowed for the pooling of knowledge and resources, enabling the creation of groundbreaking pharmaceutical technologies.

Conclusion

Kalpana Sanjay Joshi’s contributions to the field of pharmaceuticals through her numerous patents and collaborations highlight her as a pivotal figure in innovation. Her relentless pursuit of effective medical solutions continues to impact the healthcare industry positively and provides hope for many suffering from severe illnesses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…